ROYALTY PHARMA PLC- CL A (RPRX)
GB00BMVP7Y09 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Change In Working Capital | 38.43M | -113.00M | -213.30M | -11.70M | -94.50M | |||
| Interest Paid | -169.17M | -170.10M | -130.40M | -103.20M | -255.00M | |||
| OPERATING CASH FLOW | 2.99B | 2.14B | 2.02B | 2.03B | 1.67B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.12B | -1.74B | -2.19B | -2.18B | -1.72B | |||
| Other Investing Activity | 42.73M | 712.20M | 321.20M | -577.10M | -394.90M | |||
| INVESTING CASH FLOW | -2.07B | -1.03B | -1.87B | -2.76B | -2.12B | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.00B | 0.00 | 1.27B | 680.60M | -294.00M | |||
| Stock Issued/Repurchased | -304.76M | 0.00 | 0.00 | 1.91B | N/A | |||
| Dividend Paid | -358.33M | -333.30M | -285.20M | -112.50M | N/A | |||
| Other Financing Activity | -485.67M | -611.50M | -602.20M | -989.70M | -897.60M | |||
| FINANCING CASH FLOW | -2.15B | -944.90M | 385.10M | 1.49B | -1.19B | |||
| CHANGE IN CASH | -1.23B | 169.70M | 532.30M | 762.50M | -1.64B | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 2.99B | 2.14B | 2.02B | 2.03B | 1.67B | |||
| Capital Expenditure | -2.12B | -1.74B | -2.19B | -2.18B | -1.72B | |||
| FREE CASH FLOW | 872.28M | 402.40M | -174.00M | -147.60M | -54.10M | |||
All data in USD